The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...
Novo Nordisk (NVO) said Thursday Camilla Sylvest has decided to leave the company, after a distinguished career of 28 years ...
the controlling shareholder of obesity drugmaker Novo Nordisk (NOVOb.CO), opens new tab, nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024 ...
Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results